Basic research

Research on the improvement of cognitive impairment, endoplasmic reticulum stress and neuroinflammation in Alzheimer's disease by emodin

  • YANG Le ,
  • ZHOU Yi ,
  • WANG Keyun ,
  • LAI Yali
Expand
  • 1.Department of Neurology, The Second Affiliated Hospital of Chengdu Medical College, 416 Nuclear Industry Hospital, Chengdu 610041, China
    2.Department of Neurology, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu 610072, China
First author contact:YANG Le and ZHOU Yi participated in the experimental design. YANG Le, ZHOU Yi and WANG Keyun participated in experimental operations, data collection, and data analysis. YANG Le, ZHOU Yi, WANG Keyun and LAI Yali participated in the writing and editing of the paper. All authors have read and agreed to submit the final manuscript.
LAI Yali, E-mail: 838856089@qq.com.

Received date: 2024-11-18

  Accepted date: 2025-02-18

  Online published: 2025-06-28

Supported by

2020 Sichuan Province Health Research Project(20ZD009)

Abstract

Objective ·To explore the effects and potential mechanisms of emodin on Alzheimer's disease (AD). Methods ·Wild-type C57BL/6J mice and 3×Tg-AD mice were divided into 6 groups: Control group (C57BL/6J mice), AD group (3×Tg-AD mice), Emodin 25 mg/kg group (3×Tg-AD mice + Emodin 25 mg/kg), Emodin 50 mg/kg group (3×Tg-AD mice + Emodin 50 mg/kg), Emodin 100 mg/kg group (3×Tg-AD mice + Emodin 100 mg/kg) and Donepezil group (3×Tg-AD mice + Donepezil 3 mg/kg). The Morris water maze test was used to evaluate the learning and memory abilities of mice. The expression of glial fibrillary acidic protein (GFAP), glucose-regulated protein 78kDa (GRP78), and inositol-requiring enzyme 1α (IRE1α) was detected by immunohistochemistry. The levels of tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), and IL-6 in brain tissue were measured by enzyme-linked immunosorbent assay (ELISA). Western blotting was used to detect the expression of NF-κB p65, p-NF-κB p65, p38, and p-p38 proteins. Results ·Compared with the control group, mice in the AD group showed impaired cognition, increased GFAP expression, elevated levels of TNF-α, IL-1β and IL-6, and increased expression of GRP78 and IRE1α, along with enhanced phosphorylation of NF-κB p65 and p38. Compared with the AD group, emodin improved cognitive impairment of AD mice, inhibited astrocyte overactivation and neuroinflammation, and decreased the expression of GRP78, IRE1α, phosphorylated NF-κB p65, and phosphorylated p38 in brain tissue. Conclusion ·Emodin can effectively improve cognitive impairment in AD mice, which may be related to the inhibition of endoplasmic reticulum stress-mediated neuroinflammation in astrocytes.

Cite this article

YANG Le , ZHOU Yi , WANG Keyun , LAI Yali . Research on the improvement of cognitive impairment, endoplasmic reticulum stress and neuroinflammation in Alzheimer's disease by emodin[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2025 , 45(6) : 727 -734 . DOI: 10.3969/j.issn.1674-8115.2025.06.007

References

[1] JETT S, MALVIYA N, SCHELBAUM E, et al. Endogenous and exogenous estrogen exposures: how women's reproductive health can drive brain aging and inform Alzheimer's prevention[J]. Front Aging Neurosci, 2022, 14: 831807.
[2] ZHAO M, WANG Y C, SHEN Y X, et al. A review of the roles of pathogens in Alzheimer's disease[J]. Front Neurosci, 2024, 18: 1439055.
[3] AVILA J, PERRY G. A multilevel view of the development of Alzheimer's disease[J]. Neuroscience, 2021, 457: 283-293.
[4] SONG L, PIAO Z Y, YAO L F, et al. Schisandrin ameliorates cognitive deficits, endoplasmic reticulum stress and neuroinflammation in streptozotocin (STZ)-induced Alzheimer's disease rats[J]. Exp Anim, 2020, 69(3): 363-373.
[5] LIU Y H, SHANG L R, ZHOU J B, et al. Emodin attenuates LPS-induced acute lung injury by inhibiting NLRP3 inflammasome-dependent pyroptosis signaling pathway in vitro and in vivo[J]. Inflammation, 2022, 45(2): 753-767.
[6] 陈芬,袁飞飞,李伟,等.大黄素调节AMPK/TXNIP/NLRP3信号通路对子痫前期大鼠炎症反应的影响[J]. 中国临床药理学杂志, 2024, 40(14): 2068-2072.
  CHEN F, YUAN F F, LI W, et al. Effects of emodin on inflammatory response in preeclampsia rats by regulating AMPK/TXNIP/NLRP3 signaling pathway[J]. Chinese Journal of Clinical Pharmacology, 2024, 40(14): 2068-2072.
[7] XING M, MA X Y, WANG X, et al. Emodin disrupts the Notch1/Nrf2/GPX4 antioxidant system and promotes renal cell ferroptosis[J]. J Appl Toxicol, 2023, 43(11): 1702-1718.
[8] ZHOU J B, LI G H, HAN G K, et al. Emodin induced necroptosis in the glioma cell line U251 via the TNF-α/RIP1/RIP3 pathway[J]. Invest New Drugs, 2020, 38(1): 50-59.
[9] 夏能银, 徐凌云, 王钰, 等. 大黄素抗小鼠阿尔茨海默病的作用及机制分析[J]. 武汉轻工大学学报, 2023, 42(6): 47-56.
  XIA N Y, XU L Y, WANG Y, et al. Study on the effects and mechanisms of emodin in the treatment of Alzheimer's disease in mice[J]. Journal of Wuhan Polytechnic University, 2023, 42(6): 47-56.
[10] CASAS-MARTINEZ J C, SAMALI A, MCDONAGH B. Redox regulation of UPR signalling and mitochondrial ER contact sites[J]. Cell Mol Life Sci, 2024, 81(1): 250.
[11] AJOOLABADY A, LINDHOLM D, REN J, et al. ER stress and UPR in Alzheimer's disease: mechanisms, pathogenesis, treatments[J]. Cell Death Dis, 2022, 13(8): 706.
[12] SOUGIANNIS A T, ENOS R T, VANDERVEEN B N, et al. Safety of natural anthraquinone emodin: an assessment in mice[J]. BMC Pharmacol Toxicol, 2021, 22(1): 9.
[13] DOROSZKIEWICZ J, MROCZKO B. New possibilities in the therapeutic approach to Alzheimer's disease[J]. Int J Mol Sci, 2022, 23(16): 8902.
[14] MA H Y, DONG Y, CHU Y H, et al. The mechanisms of ferroptosis and its role in Alzheimer's disease[J]. Front Mol Biosci, 2022, 9: 965064.
[15] GLASS C K, SAIJO K, WINNER B, et al. Mechanisms underlying inflammation in neurodegeneration[J]. Cell, 2010, 140(6): 918-934.
[16] NANCLARES C, BARAIBAR A M, ARAQUE A, et al. Dysregulation of astrocyte-neuronal communication in Alzheimer's disease[J]. Int J Mol Sci, 2021, 22(15): 7887.
[17] VERKHRATSKY A, NEDERGAARD M. Physiology of astroglia[J]. Physiol Rev, 2018, 98(1): 239-389.
[18] FAKHOURY M. Microglia and astrocytes in Alzheimer's disease: implications for therapy[J]. Curr Neuropharmacol, 2018, 16(5): 508-518.
[19] POTOKAR M, MORITA M, WICHE G, et al. The diversity of intermediate filaments in astrocytes[J]. Cells, 2020, 9(7): 1604.
[20] WANG B, LIU Y, JIANG R, et al. Emodin relieves the inflammation and pyroptosis of lipopolysaccharide-treated 1321N1 cells by regulating methyltransferase-like 3-mediated NLR family pyrin domain containing 3 expression[J]. Bioengineered, 2022, 13(3): 6740-6749.
[21] GHEMRAWI R, KHAIR M. Endoplasmic reticulum stress and unfolded protein response in neurodegenerative diseases[J]. Int J Mol Sci, 2020, 21(17): 6127.
[22] SCHEPER W, HOOZEMANS J J M. The unfolded protein response in neurodegenerative diseases: a neuropathological perspective[J]. Acta Neuropathol, 2015, 130(3): 315-331.
[23] RAHMAN S, ARCHANA A, JAN A T, et al. Dissecting endoplasmic reticulum unfolded protein response (UPRER) in managing clandestine modus operandi of Alzheimer's disease[J]. Front Aging Neurosci, 2018, 10: 30.
[24] GRAEWERT M A, VOLKOVA M, JONASSON K, et al. Structural basis of CDNF interaction with the UPR regulator GRP78[J]. Nat Commun, 2024, 15(1): 8175.
[25] WANG Y L, ZHOU X, LI D L, et al. Role of the mTOR-autophagy-ER stress pathway in high fructose-induced metabolic-associated fatty liver disease[J]. Acta Pharmacol Sin, 2022, 43(1): 10-14.
[26] LIU Y Y, XU C L, GU R J, et al. Endoplasmic reticulum stress in diseases[J]. Med Comm (2020), 2024, 5(9): e701.
Outlines

/